Variant report
Variant | nsv998231 |
---|---|
Chromosome Location | chr1:166174516-166228386 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10918388 | chr1:166174516-166174517 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs183145810 | chr1:166174524-166174525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1451606 | chr1:166174572-166174573 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs185763135 | chr1:166174585-166174586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572915067 | chr1:166174622-166174623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190136906 | chr1:166174636-166174637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10800202 | chr1:166174646-166174647 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs544171781 | chr1:166174661-166174662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563894124 | chr1:166174671-166174672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182306616 | chr1:166174706-166174707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572184734 | chr1:166174731-166174732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543229795 | chr1:166174736-166174737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559554813 | chr1:166174780-166174781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141017836 | chr1:166174816-166174817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551315751 | chr1:166174824-166174825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10753713 | chr1:166174854-166174855 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs186633993 | chr1:166174865-166174866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558051611 | chr1:166174866-166174867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550633336 | chr1:166174879-166174880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567432133 | chr1:166174882-166174883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs536030173 | chr1:166174884-166174885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs193140030 | chr1:166174886-166174887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566530121 | chr1:166174918-166174919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10753714 | chr1:166174940-166174941 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs141805108 | chr1:166174955-166174956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs575349439 | chr1:166175098-166175099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs372325692 | chr1:166175129-166175130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4556335 | chr1:166175139-166175140 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs375599884 | chr1:166175162-166175163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs4378185 | chr1:166175222-166175223 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs184032916 | chr1:166175264-166175265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113609220 | chr1:166175267-166175268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs736874 | chr1:166175280-166175281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188481447 | chr1:166175288-166175289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572998915 | chr1:166175322-166175323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545138258 | chr1:166175334-166175335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562067851 | chr1:166175365-166175366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs193074683 | chr1:166175479-166175480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530840814 | chr1:166175495-166175496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs61835149 | chr1:166175527-166175528 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs560988550 | chr1:166175715-166175716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555441652 | chr1:166175755-166175756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs145628560 | chr1:166175824-166175825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs111812316 | chr1:166175847-166175848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs566717679 | chr1:166175863-166175864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs78912149 | chr1:166175871-166175872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs552331863 | chr1:166175880-166175881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs144265413 | chr1:166175925-166175926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537410700 | chr1:166175935-166175936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs896404 | chr1:166175936-166175937 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Developmental delay | 21147756 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:166172800-166175600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:166175600-166177400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr1:166176200-166177000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr1:166179600-166180000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr1:166203000-166203600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr1:166203200-166203400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr1:166203200-166203400 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
8 | chr1:166203200-166203600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
9 | chr1:166203200-166203800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr1:166203200-166203800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
11 | chr1:166204400-166204800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr1:166204400-166204800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr1:166204400-166205600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
14 | chr1:166204800-166207000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr1:166206800-166207200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
16 | chr1:166222000-166223400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
17 | chr1:166222400-166224000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
18 | chr1:166222600-166223400 | Enhancers | Adipose Nuclei | Adipose |
19 | chr1:166223000-166223400 | Enhancers | Psoas Muscle | Psoas |